ENDOLUCIN BETA
Live / Registered — Registered — international registration renewed (as of 16 Sept 2024)
What this means for you
Registered since 14 Nov 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79199839
- Registration number
- 5332068
- Mark type
- Design + words
- Filed
- 14 Oct 2016
- Published for opposition
- 29 Aug 2017
- Registered
- 14 Nov 2017
- Attorney of record
- David M. Kohn
Goods and services
- Class 005 — Pharmaceuticals: Radiopharmaceutical preparations, namely, precursors containing lutetium for therapeutic or diagnostic purposes; Radioactive substances for medical purposes, namely, for radio-labelling pharmaceutical compounds for use in nuclear medicine
Owner
Prosecution history
- 16 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 16 Sept 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 18 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Nov 2023 — TEAS SECTION 71 & 15 RECEIVED
- 14 Nov 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 26 Nov 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 13 Apr 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Feb 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Feb 2018 — FINAL DISPOSITION PROCESSED
- 14 Feb 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 14 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
- 29 Aug 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Aug 2017 — PUBLISHED FOR OPPOSITION
- 09 Aug 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jul 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER